万维提示：
1、投稿方式：在线投稿。
2、期刊网址：https://www.publish.csiro.au/CH
3、投稿网址：http://mc.manuscriptcentral.com/csiro-ch
4、官网邮箱：publishing.ajc@csiro.au
5、官网电话：+[61 3] 9545 8404
6、出刊日期：月刊，一年出版十二期。
2021年4月3日星期六
投稿须知【官网信息】
Author Instructions
All manuscripts should be submitted via ScholarOne Manuscripts.
Publishing Policies
Peer review
Authorship
Licence to publish
Open access
Scope and publishing policy
Submission of manuscripts - author's overview
Full Papers
Communications
Reviews
Primer Reviews
Highlights
Accounts
Focus
Use of inclusive language
Manuscript preparation
Title
Authors and addresses
Abstract
Text
Introduction
Conclusion
Symbols, units, and nomenclature
Syntheses
Compound characterization
Crystallographic data
Computational results
Equations and mathematics
Tables
Graphics
Supplementary Material
Acknowledgements
Conflicts of Interest
Declaration of Funding
Ethics approval
References
Submission of manuscripts
Reprints
Questions and correspondence
Publishing Policies
Australian Journal of Chemistry - an International Journal for Chemical Science insists on high standards of ethical behaviour throughout the publication process. Our journal editors work within the guidelines of the Committee on Publication Ethics (COPE) and International Committee of Medical Journal Editors (ICMJE). Further information on our policies can be found at http://www.publish.csiro.au/ch/PublishingPolicies.
Peer review
Australian Journal of Chemistry is a peer-reviewed journal that uses a single-blind peer-review. The Editors-in-Chief are responsible to maintain high-quality peer-review of papers submitted to the journal and work together with Associate Editors to ensure a thorough and fair peer-review and the highest scientific publishing standards. All submissions undergo preliminary assessment by an Editor-in-Chief, who may reject a paper before peer review when it is outside the journal’s scope or is of insufficient quality. Associate Editors select reviewers and after at least two review reports are received, they make the decision whether to accept/reject or send a manuscript for revision. The final decision is made by the Associate Editor.
Under our single-blind policy, reviewers’ names are not disclosed to the authors. To increase transparency, reviewers may choose to sign their reports. We ask reviewers and authors not to directly contact each other while the manuscript is under consideration, rather keep all communication through ScholarOne with the Editor’s involvement.
Papers containing new crystal structures undergo additional review by the Crystallographic Editor, who checks each crystal structure for consistency. The manuscript is also checked to ensure that comments on the structure are justified based on the quality of the determination.
Authorship
The conditions around authorship for Australian Journal of Chemistry should follow the recommendations of the International Committee of Medical Journal Editors (ICMJE), for more information see http://www.publish.csiro.au/ch/PublishingPolicies.
Licence to publish
For details regarding copyright, please see Copyright/Licence to Publish.
Open access
Authors may choose to publish their paper Open Access on payment of a publication fee. See Open Access for more details.
Scope and publishing policy
Australian Journal of Chemistry publishes research papers from all fields of chemical science. Papers that are multidisciplinary or address new or emerging areas of chemistry are particularly encouraged. Thus, the scope is dynamic. It includes (but is not limited to) synthesis, structure, mechanism, theory, new materials, macromolecules and polymers, supramolecular chemistry, analytical and environmental chemistry, natural products, biological and medicinal chemistry, nanotechnology, and surface chemistry.
The publishing policy of Australian Journal of Chemistry is to select the most important papers with the broadest significance to the wider chemistry community. Papers reporting incremental results that do not have sufficient originality and significance are unlikely to be accepted.
Submission of manuscripts - author's overview
The covering letter should contain a justification explaining the novelty and significance of the work to the general chemical community. The covering letter should also contain a statement that the manuscript has not been published elsewhere, and is being submitted exclusively to Australian Journal of Chemistry.
Australian Journal of Chemistry is a general chemistry journal with a broad readership. 80 % of the Journal´s subscribers are outside Australia. Each manuscript should include a general Introduction that allows all readers to appreciate the significance and general context of the work, along with a final paragraph summarizing the conclusions that can be drawn, and noting possible future directions. The Journal appears 12 times per year in print and on the web. Abstracts of papers are published as soon as accepted; full online versions are posted as soon as publishable.
All manuscripts should be submitted as a single file containing schemes, figures, and tables embedded in the text.
To submit your paper, please use our online journal management system ScholarOne Manuscripts, which can be reached directly through this link or from the link on the Journal´s homepage. If a first-time user, register via the ´Register here´ link, or use your existing username and password to log in. Then click on the ´Author Centre´ link and proceed. Please include the name, address, fax and telephone numbers, and email address of the corresponding author.
A Table of Contents entry must also be supplied, containing an appropriate graphic and a short (ca. 50 words) text written for interested non-experts, an example of which is shown below:
Organoboron compounds are useful building blocks for organic synthesis; however, they suffer from incompatibilities with many synthetic transformations. The recently reported N-methyliminodiacetate boronate complex shows good stability and resistance to a wide variety of chemistries. The ability to protect and mask the boron functionality has led to an expanded role for boron in the synthesis of complex molecules.
Manuscript categories
Full Papers
Full papers are complete reports of original research results that have not previously been published, except in the form of a Communication, in which case a reprint should be provided. A full paper will not be published if all relevant experimental details have already been published as supporting information in a Communication elsewhere. Evidence must be given that substantial new material is submitted, and the Communication must be identified and cited early in the manuscript. A short abstract (maximum 100 words) should be provided at the start of the manuscript. The paper should be divided into Introduction, Results and Discussion, Conclusion, and Experimental (and/or Computational Methods) sections.
Communications
Communications are short reports of urgent research findings, and should not exceed 2000 words and three graphics. A short abstract (50-100 words) should be provided at the start of the manuscript. The text should not otherwise be broken up into sections; however, an introductory paragraph should provide a general context for the work, explaining its significance, and indicating why it should be of interest to chemists in other areas, while the final paragraph should summarize the major conclusions that can be drawn, pointing to possible future directions. A short Experimental section should be included. Adequate experimental details, including full characterization of new compounds, should be given as supporting information in the Supplementary Material. The submission should be accompanied by a brief statement explaining why urgent publication is merited.
Reviews
Review articles are usually not more than 10 printed pages and should give a critical overview of a subject of high current interest in chemical science. Authors are encouraged to take a stance and lead the reader through the field. Overall a review should take us forward and show where a field is heading. The introduction should arouse the reader´s interest, describing the background, significance, and development of the field, and should be comprehensible to a broad audience. The main part of the review should be a comprehensive but critical analysis of recent (last three to five years) developments, current problems, and future directions. The review should conclude with a summary of the highlights (pointing out their significance) and unsolved problems. A passport photo and a short biography (ca. 100 words) should be submitted with the manuscript.
Primer Reviews
Primer Reviews are concise, authoritative overviews of important contemporary topics in the chemical sciences. They should appeal to advanced undergraduates, the general research chemist who is new to the field, as well as the expert. They provide a solid introduction to the development of a subject, the latest breakthrough results and their implications for the wider scientific community. These Reviews should be no longer than 12 000 words and contain a maximum of 50 citations, crediting major contributors, both old and new. Specialist terms and symbols should be defined, and fundamental ideas simply explained.
Primer Reviews must be:
Accessible: to advanced undergraduate students and beyond. Primer Reviews are often used in advanced undergraduate and Masters studies.
Authoritative: An essential introduction to the field will lay the foundation of knowledge in the area with approximately 25 seminal citations, serving as a springboard to further reading, followed by the most important recent advances.
Topical: the reviews should treat subjects where there has been significant recent advance and promote a rigorous view in a succinct form.
Highlights
Highlight articles summarize recent developments in a new, developing, controversial, or speculative field of chemistry, and are intended to serve as an introduction to the field for the general reader. A short abstract should be provided at the start of the manuscript. A strong introduction describing the significance of the work and the reason for recent heightened interest should be followed by a clear and succinct presentation of important results, without the extensive technical details required for an original article or the extensive history required for a review. The conclusion should highlight the significance of the findings and describe how they take us forward, and it should point to possible future directions. All of this should be presented in a manuscript of up to 2000 words.
Accounts
An Account is a hybrid of a Highlight and a Review. It is a personalised account highlighting an important aspect of the author’s own work (not a summary of all the work on different topics in the group). As always, due recognition of the contributions from other labs needs to be given. An Account should not be more than 10 printed pages. The same requirements of style as for a Highlight apply.
An Account may have several authors, but the senior author whose work is being highlighted should be the corresponding author. An Account should not usually describe previously unpublished results, but in cases where this is desirable, sufficient experimental or theoretical data must be published as Supplementary Material.
Focus
Focus articles are brief (1-2 published pages) accounts reporting on a new reagent, technique (e.g. particle or film preparation), or analytical/imaging method (microscopy, spectroscopy) etc. They are written by postdoctorates and postgraduates, thus providing an introduction to publishing for young scientists. The article consists of an introduction to the reagent/technique and a discussion of its significance, to how it is prepared/used, and why it represents an advance on previous reagents/methods. This is followed by single-paragraph summaries (with graphics) of recent reports of its usage. A brief biography (approximately 60 words) and a photo of the author should be submitted with the article. The total length of the article should not be greater than 600 words. In line with our Publishing Policies, the lead author’s supervisor should be included in the author list.
Use of inclusive language
These guidelines should be used to assist in identifying appropriate language, but are by no means exhaustive or definitive. Inclusive language comprises carefully chosen words and phrases that are respectful and promote the acceptance and value of all people. It is language which is free from words, phrases or tones that demean, insult, exclude, stereotype, or trivialise people on the basis of their membership of a certain group or because of a particular attribute. As such, inclusive language should make no assumptions about the beliefs or commitments of any reader, and contain nothing which might imply that one individual is superior to another on any grounds including but not limited to: age, gender, race, ethnicity, culture, sexual orientation, disability or health condition. We encourage the use of plural nouns (e.g., 'they' as default wherever possible instead of 'he/she'), and recommend avoiding the use of descriptors that refer to personal attributes, unless there is scientific or clinical relevance. For further guidance on inclusive language see Inclusive language | Style Manual. If there are questions about language use and/or publishing with regards to First Nations people, please contact the Journal.
Manuscript preparation
Line numbers must be included.
Order: The sections of a manuscript should appear as follows:
Title, Authors and Addresses, Abstract
Introduction
Results and Discussion (can be separate)
Conclusion
Experimental (and/or Computational Methods)
References
The Experimental section may, when necessary, appear in the body of the manuscript.
Title: The title should be succinct and no longer than ten words. The title should capture important keywords.
Authors and addresses: The full names of all authors contributing to the work should be included, along with their complete postal addresses. Email address(es) of the contact author(s) must be included. The addresses listed should be the institution(s) where the work was conducted; if this is different from the present address, the present address should be indicated in a footnote.
Abstract: This should state concisely the scope of the work and the principal findings in no more than 250 words. Abstracts are not published for Focus articles.
Text: Every manuscript (except Focus articles) should contain introductory and concluding paragraphs written in a general style that will allow the main points to be appreciated by a broad audience of readers across the chemical sciences. Robert Schoenfeld´s book The Chemist´s English (Wiley-VCH: Weinheim, 1989) may be useful to intending authors, but may be hard to find. A good rule is: use clear language that drives your story forward. Authors not fully fluent in the finer points of English are urged to consult native English-speaking colleagues before submitting manuscripts. Please define acronyms on their first appearance except ones commonly understood by all chemists (such as NMR and UV-vis); when in doubt include a definition. Relevant compounds should be numbered consecutively and in boldface.
Introduction: This should provide a general context for the work, explaining its significance, and indicating why it should be of interest to chemists in other areas.
Conclusion: This should summarize the major conclusions that can be drawn, pointing out their significance, and alluding to possible future directions.
Symbols, units, and nomenclature should conform to the recommendations of the International Union of Pure and Applied Chemistry. SI units should be used for physical quantities [see IUPAC recommendations on these in the Green Book (I. Mills, T. Cvitas, K. Homann, N. Kallay, K. Kuchitsu, Quantities, Units and Symbols in Physical Chemistry, 2nd edn 1993 (Blackwell: Oxford), e.g. s for second, min for minute, etc.)]. If other units must be used, their first appearance in a paper should be followed by a footnote or parenthesis giving the conversion factor. Both IUPAC and Chemical Abstracts nomenclature are acceptable. Refer to the Blue Book [R. Panico, W. H. Powell, J.-C. Richer (Eds), A Guide to IUPAC Nomenclature of Organic Compounds 1993 (Blackwell: Oxford)] and the Red Book [G. J. Leigh, (Ed.), Nomenclature of Inorganic Chemistry 1990 (Blackwell: Oxford)] for a guide to IUPAC nomenclature. For the nomenclature of polymers recommended by IUPAC, see http://www.iupac.org/publications/pac/84/10/2167/ or http://pac.iupac.org/publications/pac/pdf/2012/pdf/8410x2167.pdf.
Syntheses: should be clearly documented and logically presented, as shown in the example provided here. Compound names (rather than only numbers) should be given wherever possible. Physical data should be arranged, where possible, as follows: physical data (melting/boiling point — optical rotation) — spectroscopic data (IR — UV-vis — 1H NMR — 13C NMR — mass spectrometry) — chemical data (combustion — elemental analysis). Spectral peaks should be listed as they read from left to right in the spectrum. The order should at least be consistent within the manuscript. The names of new compounds should appear in italics where they are first mentioned in the Experimental section. Elemental analyses should be presented as: Anal. Calc. for C13H13NO4: C 63.14, H 5.30, N 5.67. Found: C 62.99, H 5.32, N 5.65 % (a tolerance of 0.4 % is usually acceptable). NMR data should be presented in the order chemical shift (multiplicity, coupling constant(s), integration, assignment). Coupling constants J should be given where appropriate. Indicate the machine frequency if non-routine, e.g. deltaH (500 MHz, CDCl3) 4.07 (q, J 7.5, 2H, CH2CH3).
Adequate evidence to establish identity and purity of new compounds should be provided. An accurate mass measurement of a molecular ion is acceptable as evidence for chemical composition provided that independent evidence for sample purity is given. In such cases, copies of 1H and 13C NMR spectra and low-resolution mass spectra must be provided as Supplementary Material. HPLC or GLPC chromatograms and low-resolution mass spectra under conditions that minimize fragmentation may be useful as additional evidence of purity.
Supplementary spectra and spectral assignments, e.g. 2D NMR spectra that are not needed for the general understanding of the text, may also be published in the Supplementary Material.
Compound characterization
Organic compounds: The requirements for organic compounds are delineated above. The same requirements apply to all small and medium-sized molecules generally, including monomers for polymerization and materials science studies. Authors are encouraged to provide copies of 1H and 13C NMR spectra of new compounds in the Supplementary Material. Such copies (together with low-resolution mass spectra) must be provided in all cases where elemental analysis is not available and high resolution mass measurement is used as a criterion of composition.
Polymers: For soluble polymers an estimation of molecular weight must be provided, e.g. size exclusion chromatography, including details of columns, eluents and calibration standards, intrinsic viscosity, MALDI TOF, etc. For insoluble and crosslinked polymers, elemental analysis (within ±0.4% of the calculated value) is required to confirm sample purity and composition. For optoelectronic compounds, UV-visible data should be reported.
Important physical properties, such as Tg and Tm, should be included for all polymers where appropriate. For all soluble polymers full NMR characterisation (1H, 13C) in support of the assigned structure, including relevant 2D NMR and related experiments (i.e. NOE, etc.) is required. Copies of these spectra should be provided in the Supplementary Material. Likewise, copies of IR spectra that support functional group modifications and other important assignments should be reproduced in the SM.
Inorganic and organometallic compounds: X-Ray data will be reported in many cases, but it is noted that this does not prove the homogeneity or composition of the bulk material. Other, supportive physical data are needed, e.g. NMR when practicable; elemental analysis and/or high resolution mass spectra and copies of relevant spectra in the Supplementary Material.
Biomaterials: Evidence for the identity of biomolecules must be described, e.g. mass spectrometry, LC-MS, sequencing data high field 1H or 13C NMR spectroscopy, or X-ray crystallography. Evidence for purity may be established by HPLC, gel electrophoresis, capillary electrophoresis, or high field 1H or 13 NMR. Likewise, when DNA or RNA oligonucleotides are used in organic synthesis, their purity must be established. The usual organic chemistry analytical requirements delineated above apply to all new monomers.
Yield and purity of all compounds and the methods used to determine them must be given. If necessary, HPLC, GC traces, or other evidence of purity and composition may be reproduced in the SM. If yields of compounds that are not isolated are reported (e.g. by GC or NMR spectroscopy) the method must be described and internal standards must be used.
Crystallographic data: Should broadly conform to the recommendations of the International Union of Crystallography. Prior to manuscript submission, the author should deposit data for organic and metal-organic structures with the Cambridge Crystallographic Data Centre. The data will be assigned one CCDC deposition number per structure, which should be quoted in the manuscript. The authors are required to run the checkCIF program and submit the output as supporting information for assessment by the referees. The crystallographic information file (cif) must also be submitted with the manuscript as supporting information for assessment by referees, but it will not be published.
Tables of relevant bond lengths and angles not needed in the general discussion but of interest to the specialist may be published in the Supplementary Material, but the full crystallographic data will not be published (e.g. atomic coordinates and anisotropic displacement parameters), as it will be available from the CCDC.
The manuscript to be published should contain a standard description of the crystal data and structure refinement in the Experimental section. This includes the chemical formula, formula mass, crystal system, space group, crystal colour, and dimensions of crystal, unit cell parameters (with standard uncertainties), data collection temperature, number of formula units in the unit cell, linear absorption coefficient, range of transmission factors, wavelength of radiation, 2 theta range, number of measured and independent reflections, number of reflections included in the refinement, goodness of fit, and final R values.
An ORTEP (or similar) diagram should be incorporated in the text. Important bond lengths and angles may be included in a table or in the figure or figure caption). If the structure is peripheral to the subject of the paper, it should be published in the Supplementary Material.
Additional views or details of the structure(s), crystal packing, etc., may, when relevant, be published in the Supplementary Material.
Computational results: These should aim to follow the IUPAC guidelines for reporting the results of calculations. Sufficient detail should be provided, within the manuscript or in the Supplementary Material, to enable readers to reproduce the calculations. Necessary detail includes, for example, force-field parameters and/or equations, or references thereto, defining the model. Results describing electronic structure calculations should provide the geometries (Cartesian coordinates or Z-matrices) and absolute energies of all calculated structures in the Supplementary Material. Where applicable, imaginary frequencies and IRC calculations should be reported to identify stable structures and transition states.
Equations and Mathematics: Equations should be numbered sequentially. Please avoid double sub- or superscripts. We recommend following the formats outlined in the Green Book (upright for constants (e, pi, i), italic for variables, bold italic for vectors and matrices).
Tables: Table numbers are designated by Arabic numerals. Tables consist of three horizontal rules, with box headings centred over each column. Material in body of table is usually justified on the left-hand side. Numerical data are usually justified on the decimal point. Footnote references within tables are superior capital letters. Footnotes appear at the bottom of the table, in the same size text as the body of the table. A simple example can be viewed here. Tables should be prepared for single-column format whenever feasible.
Graphics: Figures, Schemes and Charts should be of sufficient quality to allow direct reproduction. They should be prepared for single-column format (85 mm width) whenever possible. Double-column figures are acceptable where necessary, but attention should be paid to economical use of space. Numbers, letters, and symbols should be of the correct size to be 1.8 mm (8 pt) high after reduction. Images with grey tones or colour should be provided as high quality originals, and as electronic files in (ideally) TIFF, EPS, or PDF format with the highest resolution possible (at least 300 dpi). For scanned photographs ensure the resolution is at least 300 dpi and for colour images use RGB with the highest resolution possible. For colour images in the print version, authors will be asked to contribute towards the costs associated with colour printing. Authors may wish to choose to have their colour figures produced in colour in the online version of their paper, free of charge, and black and white in the print version.
All illustrations should have titles, even if there is no caption.
In ORTEP or similar diagrams, (selected) atoms should be labelled and the labelling should be consistent with all other atom numbering system used in the manuscript.
Symbols representing variables or physical quantities should be in italics.
Chemical structures should be produced using ChemDraw or ChemBioDraw in the style shown here, namely using standard bond angles and fixed bond lengths (wherever possible) of 0.5 cm/0.2 inches, line width 0.02 cm, bold width 0.07 cm. In general, the atom labels should be Helvetica 10 pt and compound numbers Helvetica bold 10 pt.
Supplementary Material: Supporting material of a detailed nature, which is not essential in the printed paper but may be useful to other workers, may be submitted with the manuscript (see ´Syntheses´, ´Compound characterization´, ´Crystallographic data´ and ´Computational results´). Such material will be made available on the web, and a note to this effect should be included at the end of the paper (before the Acknowledgements section).
Acknowledgements
The contribution of colleagues who do not meet all criteria for authorship should be acknowledged. Anyone included in the Acknowledgements section should have granted permission to be listed. Sources of financial support should be acknowledged in a separate ‘Declaration of Funding’ rather than here.
Conflicts of Interest
A ´Conflicts of Interest´ section should be included at the end of the manuscript. It should identify any financial or non-financial (political, personal, professional) interests/relationships that may be interpreted to have influenced the manuscript. If there is no conflict of interest, please include the statement "The authors declare no conflicts of interest".
Declaration of Funding
Under a subheading ´Declaration of Funding´ at the end of the text authors are required to declare all sources of funding for the research and/or preparation of the article, and the inclusion of grant numbers is recommended. Authors should declare sponsor names along with explanations of the role of those sources if any in the preparation of the data or manuscript or the decision to submit for publication; or a statement declaring that the supporting source had no such involvement. If no funding has been provided for the research, please include the following sentence: 'This research did not receive any specific funding'.
Ethics approval
For papers reporting work with animals, Editors should ensure that peer reviewers consider ethical and welfare issues raised by the research they are reviewing, and to request additional information from authors where needed. In situations where there is doubt as to the adherence to appropriate procedures or approval by the relevant ethics committee, editors are required to reject these papers.
In reporting research regarding human subjects, authors are required to document that a formally constituted review board (Institutional Review Board or Ethics committee) has granted approval for the research to be done, or that the principles outlined in the Declaration of Helsinki regarding human experimentation have been met. Investigators who do not have access to an institutional review board are required to provide a statement to the editor outlining why it was not possible to gain formal ethics approval. If the study is judged exempt from review, a statement from the committee is required. Authors should make an ethics statement within the manuscript to this effect. Authors should also state that the research was undertaken with appropriate informed consent of participants or guardians.
CSIRO Publishing also follows guidelines provided by the CSIRO Animal Ethics committee and CSIRO’s own guidelines on ethical human research.
References: References should be in the Vancouver style. Please ensure references are embedded within the manuscript and not in a referencing software program such as EndNote or ProCite. In-text references are presented numerically, superscript in square brackets, after any punctuation. Citations should appear in numerical order throughout the text, consistent with the reference list at the end of the main text body. The reference list should also have reference numbers in square brackets. Initials are listed before surnames. The penultimate and final name in the list should be separated by a comma, the final name should be followed by a comma. The journal title should be italicized, followed by the year of publication in boldface, the volume number in italics, and the page number upright. Books follow the order authors - title - editors - year, volume, chapter, page - publisher. Computer programs and patents follow essentially the same order with logical substitutions. Reference to internal publications, conference proceedings, and web pages should be avoided. For example[5,17-20]
[5] J. H. Burroughes, D. C. C. Bradley, A. R. Brown, M. K. Mackay, R. H. Friend, P. L. Burn, Nature 1990, 347, 539.
[17] A. B. Bloggs, C. D. Smith, in Pigments in Nature, (Ed. M. E. Brown) 1996, Vol 6. Ch. 8, pp. 98-102 (Pergamon: Chicago, IL).
[18] (a) V. Andriole, The Quinolones 2000 (Academic Press: New York, NY).
(b) Fluoroquinolone Antibiotics (Eds A. R. Ronald, D. E. Low) 2003 (Birkhäuser: Basel).
[19] Xtal ver. 3.4 (Eds S. R. Hall, D. J. du Boulay, R. Olthof-Hazekamp) 2001 (University of Western Australia: Perth).
[20] L. A Marshall, K. E. Steiner, G. A. Schieser, U.S. Patent 4 889 858 1989.
Submission of manuscripts
Initial submission
To submit your paper, please use our online journal management system ScholarOne Manuscripts, which can be reached directly through this link or from the link on the journal´s homepage. If a first-time user, register via the ´Register here´ link, or use your existing username and password to log in. Then click on the ´Author Centre´ link and proceed.
A covering letter must accompany the submission and should include the name, address, fax and telephone numbers, and email address of the corresponding author. The letter must contain a statement explaining the novelty and importance of the work and justifying its consideration for publication in the journal, that the manuscript has not been published elsewhere, and that it is being submitted exclusively to the Australian Journal of Chemistry. Five potential referees must be proposed.
Authors are advised to consult recent issues of the journal to note details of the scope of papers, headings, tables, illustrations, style, and general form. Observance of these and the following details will shorten the time between submission and publication. Poorly prepared and unnecessarily lengthy manuscripts have less chance of being accepted.
If you encounter any difficulties, or you have any queries, please contact the Publisher.
Revised Manuscript
Please include a detailed explanation of your responses to the referees´ comments and also submit a copy of the revised manuscript with the changes highlighted.
Reprints
The corresponding author(s) will be sent a PDF of their paper on publication. The use of the PDF copy is subject to the Conditions of Use.
Questions and correspondence
For any submission, assessment, or production matters, please contact:
Australian Journal of Chemistry
CSIRO Publishing
Locked Bag 10
Clayton South, Vic. 3169
Australia
Telephone +61 3 9545 8404
Email publishing.ajc@csiro.au
Committee on Publication Ethics
